Fingerprint
Dive into the research topics of 'Low PETN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically